# Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH

> **NCT00818870** · PHASE1 · COMPLETED · sponsor: **Vecta Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Vecam
- **DRUG:** Vecam

## Key facts

- **NCT ID:** NCT00818870
- **Lead sponsor:** Vecta Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818870, "Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00818870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*